SARS-CoV-2

Test Information

I am a:

${ profile.name.substring(0, profile.name.length - 1) }

Oncology/Genetics

Cepheid is expanding its Oncology portfolio to deliver life-changing technology to physicians and their cancer patients globally. We also offer a rapid test that detects the genetic risk for thrombosis.

Products

Xpert^® BCR-ABL Ultra

Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with chronic myelogenous leukemia (CML)

Xpert^® BCR-ABL Ultra p190

Sensitive and quantitative monitoring of BCR-ABL p190 and ABL mRNA in patients with chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL)

Xpert^® Bladder Cancer Detection

Detection of the presence of bladder cancer in patients with hematuria in 90 minutes

Xpert^® Bladder Cancer Monitor

Qualitative monitoring for recurrence in patients previously diagnosed with bladder cancer in 90 minutes

Xpert^® Breast Cancer STRAT4

Standardized breast cancer ESR1/PGR/ERBB2/MKi67 mRNA biomarker assessment in less than two hours

Xpert^® FII & FV

30-minute Test for Genetic Risk of Thrombosis

CE-IVD. In Vitro Diagnostic Medical Device. Not available in all countries.

Back to Top